InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
8
Disclosed sells
0
T+90 hit rate
14%
T+90 mean return
-21.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Silver Brian M., Chief Financial Officer. Officer active across 1 company, notably TScan Therapeutics, Inc.. In total, 8 reports have been recorded. Breakdown: 8 buys · 0 sell. Total volume traded: €214k. History available since 20 July 2021. The latest transaction was disclosed on 27 December 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
2,842 shares@ US$1.50471.9% of flowVoting Common StockSEC:0000899243-22-039506:0
Ideal exit: 23 Sept 2023 (T+270)
15,000 shares@ US$3.39880.071% mcap22.0% of flowVoting Common StockSEC:0000899243-22-012476:0
Ideal exit: 19 Dec 2022 (T+270)
5,000 shares@ US$6.3170.041% mcap12.8% of flowVoting Common StockSEC:0000899243-21-037149:0
Ideal exit: 18 Jun 2022 (T+270)
5,000 shares@ US$6.31712.6% of flowVoting Common StockSEC:0000899243-21-037149
Ideal exit: 18 Jun 2022 (T+270)
5,885 shares@ US$8.48350.065% mcap20.1% of flowVoting Common StockSEC:0000899243-21-035684:0
Ideal exit: 6 Jun 2022 (T+270)
5,885 shares@ US$8.483519.7% of flowVoting Common StockSEC:0000899243-21-035684
Ideal exit: 6 Jun 2022 (T+270)
1,000 shares@ US$15.005.9% of flowVoting Common StockSEC:0000899243-21-029437
Ideal exit: 16 Apr 2022 (T+270)
1,000 shares@ US$15.000.019% mcap6.1% of flowVoting Common StockSEC:0000899243-21-029437:0
Ideal exit: 16 Apr 2022 (T+270)
8 of 8 declarations
About Silver Brian M.
Silver Brian M. is the Chief Financial Officer of TScan Therapeutics, Inc. As CFO, he oversees the financial operations of the company, including financial planning and risk management. His expertise is essential in ensuring the financial stability of the organization.
